Facebook
Twitter
Telegram
Report an ErrorSELLAS Life Sciences Group Financial Ratios 2011-2024 | SLS
Annual Financial Ratios SELLAS Life Sciences Group
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.8 | -0.6 | -4.6 | -2445.5 | -0.4 | -0.7 | -0.7 | -0.7 | -1.6 | -5.2 | -6.4 | -3.2 | -1.7 |
P/S |
- | 26.8 | 12.4 | 21568.0 | - | - | - | - | - | 20.5 | 196.2 | - | - |
EPS |
-1.3 | -2.1 | -1.3 | -2.1 | -10.9 | -3.1 | -10.4 | -18.7 | -0.4 | -0.3 | -0.8 | -0.6 | -0.3 |
EV (Enterprise Value) |
39.7 M | 25.7 M | 79 M | 23.8 M | 10.2 M | 25.4 M | 44.6 M | 36 M | 143 M | 211 M | 522 M | 107 M | 7.67 M |
EBITDA per Share |
-1.36 | -2.16 | -1.63 | -0.00249 | -5.83 | -128 | -412 | -4.78 K | -6.54 K | -13 K | -11.2 K | -10.2 K | -17 K |
EV/EBITDA |
-3.1 | -438.8 | 0.0 | -0.4 | -1.3 | -0.5 | -2.3 | -3.4 | -13.3 | -3.8 | -0.4 | ||
PEG |
-0.0 | -0.0 | -0.0 | -24.46 | -0.0 | -0.01 | -0.01 | -0.01 | 0.05 | -0.08 | 0.12 | 0.04 | 0.0 |
P/B |
-3.5 | 5.5 | 4.6 | 1.5 | 1.1 | 3.6 | 7.5 | 0.6 | 7.7 | 5.2 | 82.9 | 4.1 | 1.9 |
P/CF |
-0.9 | -1.1 | -3.6 | -3.9 | -0.4 | -0.6 | -1.4 | -0.4 | -2.2 | -3.9 | -10.9 | -5.4 | -1.3 |
ROE % |
468.15 | -851.39 | -101.73 | -0.06 | -316.63 | -527.55 | -1147.54 | -82.18 | -472.89 | -98.78 | -1302.72 | -125.99 | -113.58 |
ROA % |
-600.42 | -197.21 | -78.78 | -0.04 | -116.15 | -163.58 | -70.85 | -35.78 | -77.79 | -45.48 | -87.16 | -63.60 | -37.09 |
ROCE % |
474.79 | -864.77 | -124.31 | -0.05 | -152.03 | -284.15 | -236.20 | -89.99 | -136.48 | -98.06 | -132.56 | -54.26 | -58.10 |
Current Ratio |
0.4 | 1.3 | 4.4 | 3.0 | 1.6 | 1.0 | 0.5 | 1.2 | 0.9 | 1.1 | 0.9 | 2.3 | 1.1 |
DSO |
- | - | - | - | - | - | - | - | - | 72.0 | 540.5 | - | - |
DIO |
- | - | - | - | - | - | - | - | - | 170.4 | 270.9 | - | - |
DPO |
- | 10039.3 | 6205.9 | - | - | - | - | - | - | 590.8 | 1867.1 | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | 242.4 | 811.5 | - | - |
Cash Conversion Cycle |
- | -10039.3 | -6205.9 | - | - | - | - | - | - | -348.4 | -1055.6 | - | - |
All numbers in USD currency
Quarterly Financial Ratios SELLAS Life Sciences Group
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.21 | - | -0.33 | -0.31 | -0.47 | - | -0.34 | -0.41 | -1.05 | - | -0.45 | -0.3 | -0.16 | - | -0.53 | -0.66 | -0.66 | - | -2.68 | -6.33 | -11.12 | - | -26.75 | -1.26 | -1.67 | - | -0.15 | -0.22 | -0.45 | - | -0.66 | 0.59 | -1.84 | - | -0.11 | -0.1 | -0.08 | - | -0.05 | -0.17 | -0.02 | -0.51 | -0.66 | 0.59 | -1.84 | -2.51 | -2.23 | -1.94 | -1.55 | - | -0.14 | -0.1 | -0.19 |
EBITDA per Share |
- | - | - | - | - | - | -0.35 | -0.43 | -1.05 | - | -0.44 | -0.29 | -0.15 | - | -0.53 | -0.64 | -0.64 | - | - | - | - | - | - | - | - | - | -0.11 | -0.13 | -0.19 | - | -0.61 | -1.01 | -1 | - | -0.05 | -0.06 | -0.06 | - | -0.09 | -0.13 | -0.1 | - | -0.08 | -0.09 | -0.08 | - | -0.08 | - | - | - | - | -0.12 | - |
ROE % |
202.98 | -24.65 | -80.39 | -378.28 | -239.90 | -515.90 | -542.52 | -513.41 | -483.06 | -48.79 | -64.79 | -54.16 | -56.18 | -46.64 | -115.60 | -168.57 | -204.18 | -194.86 | -200.39 | -136.96 | -201.10 | -273.54 | -488.75 | -698.44 | -868.52 | -723.14 | -747.32 | -556.28 | -251.82 | -62.93 | -196.32 | -305.54 | -440.24 | -327.26 | -343.92 | -227.18 | -165.10 | -98.90 | -192.61 | -293.68 | -148.31 | -400.08 | -377.27 | -324.49 | -472.47 | -230.22 | -213.47 | -202.67 | -183.37 | -129.25 | -54.14 | -37.12 | -37.98 |
ROA % |
-315.98 | -200.35 | -227.35 | -139.76 | -118.26 | -131.25 | -149.92 | -141.58 | -126.03 | -35.17 | -44.88 | -35.92 | -34.96 | -28.32 | -53.62 | -69.21 | -78.47 | -71.49 | -73.20 | -49.61 | -66.58 | -84.82 | -98.11 | -109.68 | -91.48 | -44.65 | -55.18 | -52.42 | -26.59 | -27.40 | -49.35 | -60.76 | -88.01 | -53.84 | -61.51 | -47.23 | -52.94 | -45.54 | -51.81 | -52.01 | -21.11 | -26.77 | -56.28 | -81.19 | -115.80 | -116.21 | -98.11 | -83.00 | -66.64 | -42.20 | -17.68 | -12.12 | -12.40 |
ROCE % |
202.74 | -27.93 | -84.65 | -385.99 | -244.37 | -517.75 | -543.98 | -513.47 | -481.55 | -47.36 | -63.42 | -53.27 | -55.20 | -45.86 | -45.86 | -29.80 | -14.53 | - | - | - | - | - | -215.56 | -431.11 | -668.36 | -698.60 | -721.18 | -528.21 | -323.39 | -86.30 | -150.20 | -191.52 | -226.31 | -197.07 | -225.58 | -190.20 | -165.57 | -103.08 | -220.18 | -308.78 | -401.87 | -365.10 | -385.02 | -287.83 | -152.15 | -19.92 | -19.92 | -45.71 | -91.42 | - | - | -45.71 | - |
Current Ratio |
1.7 | 0.4 | 0.7 | 1.4 | 1.8 | 1.3 | 1.9 | 2.5 | 1.2 | 4.4 | 3.4 | 4.3 | 3.4 | 2.5 | 2.5 | 2.5 | 2.5 | 1.6 | 1.6 | 1.6 | 1.6 | 1.4 | 1.4 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | 1.1 | 0.6 | 1.8 | 1.8 | 1.8 | 1.2 | 1.2 | 1.2 | 1.2 | 1.9 | 1.9 | 1.9 | 1.9 | 1.1 | 1.1 | 1.1 | 1.1 | 2.0 | 2.0 | 2.0 | 2.0 | 1.5 | 1.5 | 1.5 | 1.5 |
DSO |
- | - | - | - | - | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 38.8 | 48.1 | - | 101.0 | 78.1 | 115.9 | 234.0 | 287.2 | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 201.1 | 150.0 | - | 204.1 | 172.2 | 143.5 | - | 136.5 | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | 2274.9 | - | - | 2110.6 | 3196.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 311.4 | 404.4 | - | 767.9 | 597.2 | 575.9 | - | 940.8 | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 239.9 | 198.1 | - | 305.1 | 250.4 | 259.4 | 234.0 | 423.8 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | -2229.2 | - | - | -2110.6 | -3196.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -71.4 | -206.3 | - | -462.7 | -346.8 | -316.5 | 234.0 | -517.0 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency